MEG3, as a Competing Endogenous RNA, Binds with miR-27a to Promote PHLPP2 Protein Translation and Impairs Bladder Cancer Invasion-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MEG3, as a Competing Endogenous RNA, Binds with miR-27a to Promote PHLPP2 Protein Translation and Impairs Bladder Cancer Invasion

Published:2019-06 Issue: Volume:16 Page:51-62
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Huang Chao,Liao Xin,Jin Honglei,Xie Fei,Zheng Fuxing,Li Jingxia,Zhou Chenfan,Jiang Guosong,Wu Xue-Ru,Huang Chuanshu

Funder

NIH/National Cancer Institute

NIH/NIEHS

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference36 articles.

1. Bladder cancer;Kamat;Lancet,2016

2. Cancer Statistics, 2017;Siegel;CA Cancer J. Clin.,2017

3. From the RNA world to the clinic;Sullenger;Science,2016

4. Long Noncoding RNAs in Cancer Pathways;Schmitt;Cancer Cell,2016

5. Mechanisms of long noncoding RNA function in development and disease;Schmitz;Cell. Mol. Life Sci.,2016

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LncRNA MEG3 Inhibits the Epithelial-mesenchymal Transition of Bladder Cancer Cells through the Snail/E-cadherin Axis;Current Medical Science;2024-07-11

2. A Comprehensive Bioinformatic Analysis Identifies a Tumor Suppressor Landscape of the MEG3 lncRNA in Breast Cancer;Indian Journal of Surgical Oncology;2024-06-27

3. Association of lncRNA MEG3 rs941576 polymorphism, expression profile, and its related targets with the risk of obesity-related colorectal cancer: potential clinical insights;Scientific Reports;2024-05-04

4. RhoGDIβ inhibition via miR‐200c/AUF1/SOX2/miR‐137 axis contributed to lncRNA MEG3 downregulation‐mediated malignant transformation of human bronchial epithelial cells;Molecular Carcinogenesis;2024-02-20

5. Tumorigenesis of basal muscle invasive bladder cancer was mediated by PTEN protein degradation resulting from SNHG1 upregulation;Journal of Experimental & Clinical Cancer Research;2024-02-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3